Credential Qtrade Securities’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.61M Buy
8,834
+183
+2% +$31.5K 0.09% 102
2023
Q4
$1.34M Sell
8,651
-657
-7% -$95.8K 0.08% 110
2023
Q3
$1.39M Sell
9,308
-451
-5% -$66.2K 0.09% 111
2023
Q2
$1.31M Sell
9,759
-128
-1% -$18.8K 0.08% 111
2023
Q1
$1.58M Buy
9,887
+193
+2% +$29.5K 0.1% 101
2022
Q4
$1.57M Buy
9,694
+262
+3% +$40.2K 0.11% 96
2022
Q3
$1.27M Buy
9,432
+4,220
+81% +$606K 0.1% 103
2022
Q2
$798K Buy
5,212
+4,637
+806% +$709K 0.06% 148
2022
Q1
$93.2K Sell
575
-33
-5% -$4.79K 0.01% 266
2021
Q4
$82.3K Buy
608
+33
+6% +$3.9K 0.01% 271
2021
Q3
$62K Hold
575
﹤0.01% 264
2021
Q2
$64.8K Hold
575
0.01% 274
2021
Q1
$62.2K Buy
575
+72
+14% +$7.7K 0.01% 266
2020
Q4
$53.9K Buy
+503
New +$48.3K 0.01% 240
2019
Q3
Sell
-131
Closed -$9.53K 275
2019
Q2
$9.53K Buy
+131
New +$10.3K ﹤0.01% 240
2019
Q1
Sell
-5,153
Closed -$475K 271
2018
Q4
$475K Sell
5,153
-1,905
-27% -$168K 0.1% 115
2018
Q3
$668K Buy
+7,058
New +$669K 0.14% 104

Other funds holding ABBV

Credential Qtrade Securities's ABBV Position: Q1 2024 in Review

Credential Qtrade Securities increased its AbbVie (ABBV) stake by 2.1% in Q1 2024, buying an estimated $31.5K and bringing the position to 8,834 shares worth $1.61M. The position accounts for 0.09% of the portfolio, ranked #102.

Credential Qtrade Securities first reported a position in ABBV in Q3 2018 and has held it in 17 quarters since. 3,380 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Credential Qtrade Securities held 8,834 shares of AbbVie worth $1.61M as of Q1 2024.
  • Credential Qtrade Securities bought 183 AbbVie shares in Q1 2024, an estimated $31.5K.
  • AbbVie made up 0.09% of Credential Qtrade Securities's portfolio in Q1 2024, its #102 holding.
  • Credential Qtrade Securities first reported a position in AbbVie in Q3 2018 and has held it in 17 quarters since.
  • 3,380 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Credential Qtrade Securities's 13F filing for Q1 2024, filed 21 Jul 2025.